DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00252863
Collaborator
(none)
1,600
167
17
9.6
0.6

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether Symbicort dosed according to the Symbicort Maintenance and Reliever Therapy (SMART) concept is superior to standard asthma treatment according to the local German treatment guidelines.

Condition or Disease Intervention/Treatment Phase
  • Drug: Symbicort, used twice daily (b.i.d) and as needed (prn)
  • Drug: Budesonide Turbuhaler 200 µg
  • Drug: Fluticasone Discus 250 µg
  • Drug: Formoterol Turbuhaler 4.5 µg
  • Drug: Terbutaline Turbuhaler 0.5 mg
  • Drug: Salbutamol pressurized metered dose inhaler (pMDI) 100 µg
  • Drug: Salmeterol Discus 50 µg
  • Drug: Budesonide/Formoterol Turbuhaler 160/4.5 µg
  • Drug: Fluticasone/Salmeterol Discus 250/50 µg
  • Drug: Fluticasone/Salmeterol Discus 500/50 µg
  • Drug: Theophylline 200 mg
  • Drug: Theophylline 300 mg
  • Drug: Singulair 10 mg
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 µg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-Week, Randomised, Open-Label, Parallel-Group, Multicentre Study
Study Start Date :
Dec 1, 2004
Actual Study Completion Date :
May 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Time to first severe asthma exacerbation []

Secondary Outcome Measures

  1. Number of severe asthma exacerbations []

  2. Mean use of as-needed medication []

  3. Change in forced expiratory volume in 1 second (FEV1) from the end of run-in to the end of the study period []

  4. Prescribed asthma medication during the treatment period []

  5. Asthma Control Questionnaire (ACQ) []

  6. Patient's satisfaction with the treatment question []

  7. Health care contacts []

  8. Asthma medication []

  9. Time lost from paid and unpaid work []

  10. Serious adverse events (SAEs) []

  11. Discontinuations due to adverse events (AEs) []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with asthma, either well-controlled on a regular therapy with a combination of long-acting beta-agonists and inhaled corticosteroids or symptomatic on therapy with inhaled corticosteroids alone.
Exclusion Criteria:
  • Any other significant lung disease other than asthma

  • Any disease that might put patients at risk if they participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Site Stuttgart Baden-Württemberg Germany
2 Research Site München Bayern Germany
3 Research Site Cottbus Brandenburg Germany
4 Research Site Frankfurt Hessen Germany
5 Research Site Rostock Mecklenburg-Vorpommern Germany
6 Research Site Hannover Niedersachsen Germany
7 Research Site Düsseldorf Nordrhein-Westfalen Germany
8 Research Site Münster Nordrhein-Westfalen Germany
9 Research Site Mainz Rheinland-Pfalz Germany
10 Research Site Saarbrücken Saarland Germany
11 Research Site Halle Sachsen-Anhalt Germany
12 Research Site Dresden Sachsen Germany
13 Research Site Bad Segeberg Schleswig-Holstein Germany
14 Research Site Jena-Maua Thüringen Germany
15 Research Site Amberg Germany
16 Research Site Aschaffenburg Germany
17 Research Site Auerbach Germany
18 Research Site Augsburg Germany
19 Research Site Backnang Germany
20 Research Site Bad Arolsen Germany
21 Research Site Bad Doberan Germany
22 Research Site Bad Lippspringe Germany
23 Research Site Bad Neuenahr Germany
24 Research Site Bad Reichenhall Germany
25 Research Site Bad Sessendorf Germany
26 Research Site Bayreuth Germany
27 Research Site Bensheim Germany
28 Research Site Bergisch Gladbach Germany
29 Research Site Berlin Germany
30 Research Site Bitte Eintragen Germany
31 Research Site Bochum Germany
32 Research Site Bonn Germany
33 Research Site Borna Germany
34 Research Site Brake Germany
35 Research Site Burgwedel Germany
36 Research Site Burg Germany
37 Research Site Castrop-Rauxel Germany
38 Research Site Chemnitz Germany
39 Research Site Coswig Germany
40 Research Site Cottbus Germany
41 Research Site Damme Germany
42 Research Site Darmstadt Germany
43 Research Site Deggendorf Germany
44 Research Site Dillingen Germany
45 Research Site Dinslaken Germany
46 Research Site Dortmund Germany
47 Research Site Dresden Germany
48 Research Site Dülmen Germany
49 Research Site Düsseldorf Germany
50 Research Site Eisenach Germany
51 Research Site Eisenhüttenstadt Germany
52 Research Site Emden Germany
53 Research Site Erfurt Germany
54 Research Site Erkelenz Germany
55 Research Site Eschwege Germany
56 Research Site Flensburg Germany
57 Research Site Forchheim Germany
58 Research Site Frankenthal Germany
59 Research Site Frankfurt Germany
60 Research Site Freiberg Germany
61 Research Site Freiburg Germany
62 Research Site Freising Germany
63 Research Site Fulda Germany
64 Research Site Fürstenwalde Germany
65 Research Site Fürth Germany
66 Research Site Gelsenkirchen Germany
67 Research Site Gießen Germany
68 Research Site Gotha Germany
69 Research Site Göppingen Germany
70 Research Site Günzburg Germany
71 Research Site Gütersloh Germany
72 Research Site Hagen Germany
73 Research Site Halle Germany
74 Research Site Hamburg Germany
75 Research Site Hamm Germany
76 Research Site Hannover Germany
77 Research Site Harpstedt Germany
78 Research Site Hartha Germany
79 Research Site Heidelberg Germany
80 Research Site Heilbronn Germany
81 Research Site Homburg-Saar Germany
82 Research Site Hoyerswerda Germany
83 Research Site Iserloh Germany
84 Research Site Kamenz Germany
85 Research Site Kamen Germany
86 Research Site Kamp-Lintfort Germany
87 Research Site Karlsruhe Germany
88 Research Site Kassel Germany
89 Research Site Kaufbeuren Germany
90 Research Site Kempten Germany
91 Research Site Kiel Germany
92 Research Site Kitzingen Germany
93 Research Site Koblenz Germany
94 Research Site Krefeld Germany
95 Research Site Kronach Germany
96 Research Site Köln Germany
97 Research Site Landsberg Germany
98 Research Site Leipzig Germany
99 Research Site Leonberg Germany
100 Research Site Leverkusen Germany
101 Research Site Ludwigsburg Germany
102 Research Site Lörrach Germany
103 Research Site Lübeck Germany
104 Research Site Lüneburg Germany
105 Research Site Magdeburg Germany
106 Research Site Mainaschaff Germany
107 Research Site Mainz Germany
108 Research Site Marburg Germany
109 Research Site Markkleeberg Germany
110 Research Site Memmingen Germany
111 Research Site Moers Germany
112 Research Site Mönchengladbach Germany
113 Research Site Mühlhausen Germany
114 Research Site München Germany
115 Research Site Neubrandenburg Germany
116 Research Site Neuss Germany
117 Research Site Neuwied Germany
118 Research Site Niesky Germany
119 Research Site Nordhausen Germany
120 Research Site Oberhausen Germany
121 Research Site Oranienburg Germany
122 Research Site Oschersleben Germany
123 Research Site Paderborn Germany
124 Research Site Passau Germany
125 Research Site Peine Germany
126 Research Site Pforzheim Germany
127 Research Site Pinneberg Germany
128 Research Site Potsdam Germany
129 Research Site Ratingen Germany
130 Research Site Recklinghausen Germany
131 Research Site Regensburg Germany
132 Research Site Reutlingen Germany
133 Research Site Rheine Germany
134 Research Site Rodenbach Germany
135 Research Site Rostock Germany
136 Research Site Rottweil Germany
137 Research Site Rudolstadt Germany
138 Research Site Saalfeld Germany
139 Research Site Saarbrücken Germany
140 Research Site Saarlouis Germany
141 Research Site Salzgitter Germany
142 Research Site Sangerhausen Germany
143 Research Site Schleswig Germany
144 Research Site Schwabach Germany
145 Research Site Schwerin Germany
146 Research Site Schwäbisch Gmünd Germany
147 Research Site Siegen Germany
148 Research Site Simmern Germany
149 Research Site Sindelfingen Germany
150 Research Site Singen Germany
151 Research Site Solingen Germany
152 Research Site Stade Germany
153 Research Site Stadthagen Germany
154 Research Site Steinhagen Germany
155 Research Site Stuttgart Germany
156 Research Site Trier Germany
157 Research Site Ulm Germany
158 Research Site Uttenreuth Germany
159 Research Site Wardenburg Germany
160 Research Site Wedel Germany
161 Research Site Weinheim Germany
162 Research Site Weyhe Germany
163 Research Site Witten Germany
164 Research Site Worpswede Germany
165 Research Site Würzburg Germany
166 Research Site Zerbst Germany
167 Research Site Zwickau Germany

Sponsors and Collaborators

  • AstraZeneca

Investigators

  • Principal Investigator: Heinrich Worth, MD, Klinikum Fürth

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00252863
Other Study ID Numbers:
  • D5890L00011
  • DESOLO
First Posted:
Nov 15, 2005
Last Update Posted:
Mar 17, 2009
Last Verified:
Mar 1, 2009

Study Results

No Results Posted as of Mar 17, 2009